Increased cerebrovascular resistance in cirrhotic patients with ascites.
about
Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.Review article: albumin in the treatment of liver diseases--new features of a classical treatment.Review article: pharmacological treatment of hepatorenal syndrome.Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.Clinical use of albumin in hepatology.Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?Critical care of the end-stage liver disease patient awaiting liver transplantation.Hepatorenal syndrome in the intensive care unit.Acute kidney injury in patients with cirrhosis: perils and promise.Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.Pathophysiology of portal hypertension and its clinical links.Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients.Ammonia toxicity: from head to toe?Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.Review article: the role of the microcirculation in liver cirrhosis.Left Ventricular Myocardial Mechanics in Cirrhosis: A Speckle Tracking Echocardiographic Study.Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.Cerebral vascular resistance in hepatic insufficiency
P2860
Q33578206-04D192F9-9C80-4857-85B0-5EF8665D6416Q34542843-CE5E6B73-04BF-43F2-9C46-02BFCD1041E7Q34992519-0C9E3220-1447-473C-BCEE-7417644B951EQ35873840-5CECC1D7-598C-498D-A350-20D456D8DF07Q36428010-DF4F5D14-1988-426F-8B33-CC5282E7B511Q36772257-D575E9A8-3957-441A-A218-BE3D320F3B03Q37655017-AA9C76DD-A5FB-443C-AD85-93A4F7237DF5Q37693300-AAF676B8-136B-4E6F-8695-E1E4B21ED453Q37867071-14D54E4F-4EE6-48F9-99C3-D8BAF84201A8Q37920945-31F70EBB-868F-47F6-B730-00C5C858ECF5Q38098777-223B5152-19C5-46F5-94B9-792D3A9DC015Q38188048-ADE69468-6190-45FB-AC80-080E59D2FFBBQ38195834-7924AC13-FAC3-4F13-87FE-C1227D6B6AD3Q38371453-5C39F3CB-68B9-424F-B9AA-37E58E45D5D1Q38888375-B76B771E-5B5E-4DE7-8761-DF32A509EB86Q39052232-D542F37B-39EE-417E-9025-266248AF5D68Q41458764-89CD3E72-ED03-4044-8BAA-B1684727A702Q47812599-FEC4B41B-F807-47D3-BE63-6557F8536AF8Q48661128-BCD5E5E3-EF79-4650-83F0-418EC03AF406Q48909759-B96C2053-B34C-436A-9981-E35E7CDBC821Q57763902-8FF6D6CC-E520-47A2-BE2C-59CD85A35380
P2860
Increased cerebrovascular resistance in cirrhotic patients with ascites.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@en
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@nl
type
label
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@en
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@nl
prefLabel
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@en
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@nl
P2093
P2860
P50
P356
P1433
P1476
Increased cerebrovascular resistance in cirrhotic patients with ascites.
@en
P2093
P2860
P356
10.1002/HEP.510280107
P407
P577
1998-07-01T00:00:00Z